| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,830 | $30 | $164.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 36,400 | $1 | $145.6K |
| J3262 | Injection, tocilizumab, 1 mg | 23,890 | $10 | $119.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 8,350 | $10 | $91.8K |
| J0897 | Injection, denosumab, 1 mg | 4,860 | $20 | $87.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,170 | $30 | $85.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 660 | $100 | $63.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 230 | $110 | $24.7K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 290 | $60 | $17.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $130 | $8.9K |